https://www.marketscreener.com/quote/stock/SPECTRUM-PHARMACEUTICALS--10921/news/Spectrum-Pharmaceuticals-FDA-Grants-Orphan-Drug-Exclusivity-to-EVOMELA-melphalan-for-Injectio-22202823/?utm_source=telegram&utm_medium=social&utm_campaign=share